Related Experiment Videos
The pediatric research equity act and oncology
1Office of Cellular, Tissue and Gene Therapy, Center for Biologics Evaluation and Research, Food and Drug Administration, 1401 Rockville Pike, HFM-755, Rockville, MD 20852,USA. hirschfeld@cber.fda.gov
Pediatric Blood & Cancer
|July 6, 2004
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Addressing the Health Care Needs of Displaced Populations Following a Disaster: Development of Clinical Tools and Tracking Methods.
Disaster medicine and public health preparedness·2025
Addressing the Healthcare Needs of Displaced Populations with Chronic Illness Following a Disaster: Examples from the US Public Health Service Federal Medical Station Experience.
Disaster medicine and public health preparedness·2025
First-in-human phase 1 study of the ICOS agonist feladilimab on patients with advanced solid tumors.
Journal for immunotherapy of cancer·2025
INDUCE-2: A Phase I/II, open-label, two-part study of feladilimab in combination with tremelimumab in patients with advanced solid tumors.
Cancer immunology, immunotherapy : CII·2024
Designing a Visit Schedule for Longitudinal Studies in Pediatric Research.
Frontiers in pediatrics·2022
Navigating Voriconazole in Pediatrics: Dosing Dilemmas and Monitoring Madness.
Pediatric blood & cancer·2026
Traditional Risk Factors Are Not Associated with the Rise of Early-Onset Colorectal Cancer: An All of Us Study.
Diseases of the colon and rectum·2026
Diabetic ketoacidosis associated with pancreatic involvement in a patient with von Hippel-Lindau syndrome: a case report.
Frontiers in endocrinology·2026